LW402
/ Longwood Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 23, 2025
Phase II Study of LW402 in Moderate-to-Severe Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=144 | Completed | Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd.
New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 1
Of
1
Go to page
1